Literature DB >> 10805469

Additional findings in Galloway-Mowat syndrome.

K Kucharczuk1, A M de Giorgi, J Golden, L Zacharowicz, L P van den Heuvel, B S Kaplan.   

Abstract

The Galloway-Mowat syndrome consists of early onset nephrotic syndrome and central nervous system anomalies. Additional anomalies including hiatal hernias have been reported but are not consistently present. Various renal histopathologic changes have been reported and it is unclear whether these represent heterogeneity within the syndrome or different stages of disease progression. We describe a patient with Galloway-Mowat syndrome who had a renal biopsy at 9 months that showed minimal changes. She died at 42 months at which time the renal autopsy finding was diffuse mesangial sclerosis. Neuropathologic findings included a small brain with cerebral dysplasia, leukomalacia and absence of the cerebellar granular layer without leptomeningeal heterotopia. The autopsy also revealed bilateral ovarian agenesis. This is the first report of serial histopathologic changes and ovarian agenesis in Galloway-Mowat syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 10805469     DOI: 10.1007/s004670050783

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  3 in total

1.  Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis.

Authors:  Nesrin Besbas; Umut Selda Bayrakci; Gulsev Kale; Ali Bulent Cengiz; Zuhal Akcoren; Devrim Akinci; Ilke Kilic; Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2006-03-08       Impact factor: 3.714

2.  Collapsing Glomerulopathy in a Child with Galloway-Mowat Syndrome.

Authors:  Cengiz Zeybek; Gokalp Basbozkurt; Salih Hamcan; Ayhan Ozcan; Davut Gul; Faysal Gok
Journal:  Case Rep Nephrol       Date:  2016-06-14

Review 3.  Familial forms of nephrotic syndrome.

Authors:  Gianluca Caridi; Antonella Trivelli; Simone Sanna-Cherchi; Francesco Perfumo; Gian Marco Ghiggeri
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.